Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline for Idiopathic Gastroparesis
NCT00765895Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nortriptyline in idiopathic gastroparesis (IG), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2009; status: completed.
02
Drugs
nortriptyline
03
Conditions
idiopathic gastroparesis (IG)
Beyond the preview
Go deeper on NCT00765895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765895.